Be sure to fill out your schedule before events book up!
avatar for Thomas Hitchcock

Thomas Hitchcock

Xycrobe Therapeutics, Inc.
Founder & CEO
Thomas holds a doctorate in molecular genetics from Clemson University where he did his research on DNA damage and repair. He has completed postdoctoral training at both Duke University in the Biomedical Engineering Department and Yale University in the Program in Vascular Biology and Therapeutics where he was involved in ground-breaking research and development of in vitro engineered human cardiovascular and pulmonary tissues. He has also performed research at Weill Cornell Medical College in the Department of Oncology and Hematology where he studied multiple myeloma genetics. His findings have been both presented to the scientific community and published in noteworthy scientific journals, such as the Journal of Biological Chemistry and the Annals of the New York Academy of Sciences.

In addition to his research, Dr. Hitchcock has worked closely with the medical and marketing teams for industry leaders such as Boehringer Ingelheim and Bayer and was the Director of Medical Affairs for Ulthera, Inc., where he was part of the team that brought their platform technology to acquisition in July 2014 by Merz pharmaceuticals for $600 million.

Twitter Feed